StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
VITAL.NS$51.97+0.37%
Fair $51.97+0.0%

VITAL.NS

VITAL.NS

Basic Materials / Specialty ChemicalsNSE

$51.97

+0.20 (+0.37%)

Fairly Valued+0.0%Fair Value $51.97Fund rank 25/100 · Data gapFallback financials|
SA 38/D
F-Score: 7/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 21%

FCF escenarios

weak_data · normalized FCF $-178.2M · quality 56.7/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 19/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

38/100

D

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. ROE is 4.4%, below the 5% threshold
Thesis & Journal · VITAL.NSLocal privado en este navegador · VITAL.NS
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.2B

P/E

44.4x

↑

EV/EBITDA

13.1x

↑

ROE

4.4%

↑

Gross Margin

17.1%

↓

Debt/Equity

0.52

↑
52-Week Range$52
$35$72

TradingView lightweight chart

VITAL.NS price, volumen y niveles de valoración

Último $54.70Periodo -66.5%
Fair value: $51.97

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+32.5%

FCF CAGR

—

FCF margin

-29.6%

FCF / Net income

-9.77x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.34B · net income $40.6M · FCF $-396.2M

2022-FY → 2025-FY

Gross margin

17.1%-9.3% pts

Operating margin

4.8%-14.0% pts

Net margin

3.0%-10.7% pts

FCF margin

-29.6%+8.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.34B$1.34B$982.7M$1.17B$576.1M
Net Income$40.6M$40.6M$-13.0M$80.5M$79.0M
EBITDA$131.2M$131.2M$29.6M$143.7M$114.6M
EPS1.691.69-0.544.503.30
Gross Margin17.1%17.1%16.6%23.8%26.4%
Operating Margin4.8%4.8%-2.1%11.0%18.8%
Net Margin3.0%3.0%-1.3%6.9%13.7%
Balance Sheet
Debt/Equity0.520.520.310.322.48
Current Ratio1.531.53———
Cash Flow
Free Cash Flow$-396.2M$-396.2M$-68.2M$-178.2M$-219.2M
Returns
ROE4.4%4.4%-1.5%9.0%54.0%
Valuation
P/E44.4244.42—21.17—
EV/EBITDA13.1113.1172.4611.74—
P/B1.351.352.241.90—
Growth & Yield
Revenue Growth36.3%36.3%-15.8%102.6%—
EPS Growth410.8%410.8%-112.1%36.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

39.7%

muy exigente

EPS terminal req.

$4.61

Spread vs growth

371.1%

5Y implied EPS CAGR

27.0%

muy exigente

EPS terminal req.

$5.58

Spread vs growth

383.8%

10Y implied EPS CAGR

18.2%

exigente

EPS terminal req.

$8.99

Spread vs growth

392.6%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -19.9%

Total return

-19.9%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.54 → 1.69

Residual

-19.9%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-19.9%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.